2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Psychosocial Oncology: Addressing the emotional and mental health needs of patients.
Psychosocial oncology focuses on addressing the psychological and emotional needs of cancer patients and their families, recognizing that a cancer diagnosis affects more than just the body. The mental and emotional impact can be profound, with patients often experiencing feelings of anxiety, depression, and fear of the unknown. Psychosocial oncology provides a range of support services such as counseling, psychological therapies, and peer support groups, helping individuals cope with the stress and emotional turmoil of cancer treatment. This field emphasizes the importance of communication, not only between healthcare providers and patients but also among family members, fostering a supportive environment. By tackling the emotional challenges alongside the physical aspects of cancer care, psychosocial oncology aims to improve the overall well-being of patients, helping them maintain hope, resilience, and a sense of control during their journey.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China